chris viehbacher is out as ceo of the french drug maker.he chairman will serve as interim ceo while the company searches for a successor. viehbacher sought to dismiss speculation about his future. in fact, we discussed the situation during yesterday's show. >> don't you think this is a little embarrassing? i like christ viehbacher. he's been on the show very much. the don't fire me approach has this, well, maybe i shouldn't buy that stock. >> i get when you get to the point of asking not to be fired, you're probably going to be. >> it's like geno smith, intercepted repeatedly. >> we'll see if that prediction came true. by the way, yesterday the stock suffered, of course, but of competition in the diabetes franchise particularly and this concern he would conceivably lose his job, which they followed through and did fire him. >> it does have a hewlett-packard feel to it. who wants that job now? who wants that ceo job, david? >> i don't know. i can tell you a search has been going on for a while. >> while he was the ceo, they did a behind-his-